CellPrime
26 Results
高级搜索
-
-
Press Release: Merck Introduces CellPrime™ Recombinant Human Lysozyme for Increased Protein Recovery From E. coli Production Systems
Merck, today announced the launch of CellPrime™ recombinant human lysozyme for increased recovery efficiencies in biopharmaceutical production. -
Non-animal Origin Supplements | Biopharmaceutical Manufacturing | Merck
Merck offers a variety of non-animal origin supplements, specifically formulated for cell culture applications. -
Cell Culture Ingredients and Supplements | Biopharmaceutical Manufacturing | Merck
Our portfolio of cell culture ingredients and supplements can help you stabilize your processes and obtain optimal yields with consistent results. -
Press Release: Merck Announces Exclusive Supply and Marketing Agreement With Ventria Bioscience to Expand its CellPrime™ Line of Non-animal Origin Products
Merck, today announced an exclusive collaboration with Ventria Bioscience through which Ventria will manufacture and supply a recombinant product that meets the requirements for use as a raw material in cGMP biopharmaceutical production. -
Cleavage, Lysis and Purification after Harvest | Biopharmaceutical Manufacturing | Merck
Our products for the processing steps that follow cell harvest include Benzonase® endonuclease for DNA removal and lysozomes for cell lysis. -
Press Release: Merck Announces Exclusive Agreement with Julphar Diabetes to Offer Non-animal Origin, Recombinant Human Insulin as Cell Culture Media Supplement
Merck, today announced an exclusive agreement to sell recombinant human insulin manufactured by the United Arab Emirates-based pharmaceutical production company Julphar Diabetes. -
病毒安全保证| 预防 | Merck
用于生物治疗制品的细胞系需要在使用前进行表征研究，以确认内源性病毒水平，以及是否存在外源病毒